Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Tailored Antiplatelet Therapy With Early Escalation and Late De-Escalation Strategy Versus Standard Dual Antiplatelet Therapy in Patients Undergoing Complex High-Risk Percutaneous Coronary Intervention

NCT03465644 is registered in ClinicalTrials.gov with Duk-Woo Park, MD as lead sponsor.

NCT NCT03465644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03465644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Tailored Antiplatelet Therapy With Early Escalation and Late De-Escalation Strategy Versus Standard Dual Antiplatelet Therapy in Patients Undergoing Complex High-Risk Percutaneous Coronary Intervention
Lead sponsor
Duk-Woo Park, MD
Phase
Phase 4
Overall status
Completed
Start date
February 12, 2019
Completion date
February 13, 2025
Enrollment
2,018 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

coronary stenoses